RECURRENT OVARIAN CANCER
Clinical trials for RECURRENT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ancient herb joins fight against tough ovarian cancer
Disease control Recruiting nowThis study is testing whether adding Ashwagandha, an herbal supplement, to a standard chemotherapy drug (DOXIL) can help control ovarian cancer that has returned after initial treatment. The first part of the study will find the safest dose of Ashwagandha to combine with chemo. T…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sham Sunder Kakar • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Eye drop showdown: protecting vision during ovarian cancer fight
Disease control Recruiting nowThis study aims to find the best way to protect patients' eyes from side effects caused by a targeted ovarian cancer drug called mirvetuximab soravtansine. It will enroll 100 women with recurrent ovarian cancer whose tumors have a specific marker. Participants will be randomly as…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis study is testing a new drug called ubamatamab, given alone or with another drug (cemiplimab), for people with recurrent ovarian, fallopian tube, peritoneal, or endometrial cancers. The main goals are to find a safe and effective dose and to see if the treatment can shrink tu…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC